For the Inventor, By the Inventor

Enter assignee name

Nanobiotix

USPTO Granted Patents = 16

CIPO Patents = 2

EPO Patents = 14

Trademarks = 12

Forward Citations = 62

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Laurent Levy (16 out of 27 patents)

Agnes Pottier (9 out of 13 patents)

Matthieu Germain (7 out of 12 patents)

4. Marie-Edith Meyre (6 out of 16 patents)

5. Agnès Pottier (3 out of 12 patents)

6. Laurence Poul (3 out of 5 patents)

7. Julie Marill (2 out of 2 patents)

8. Elsa Borghi (2 out of 4 patents)

9. Agnés Pottier (2 out of 2 patents)

10. Laurence Maggiorella (2 out of 2 patents)

11. Paras Nath Prasad (2 out of 15 patents)

12. Earl Jim Bergey (2 out of 6 patents)

13. Abdel Kader Boussaha (2 out of 2 patents)

14. Jérémy Balencie (2 out of 2 patents)

15. Audrey Darmon (1 out of 3 patents)

16 patents: Sort by Forward Citations

1. 11229705 - Coated nanoparticles for use for modulating electrical polarization of neurons (2022-01-25),

2. 11096962 - Nanoparticles for use as a therapeutic vaccine (2021-08-24),

3. 11020480 - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer (2021-06-01),

4. 10945965 - Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof (2021-03-16),

5. 10588987 - Compositions and methods for use in medical diagnosis (2020-03-17),

6. 10413509 - Pharmaceutical composition, preparation and uses thereof (2019-09-17),

7. 10391174 - Metallic nanoparticles, preparation and uses thereof (2019-08-27),

8. 10391058 - Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof (2019-08-27),

9. 10265406 - Pharmaceutical composition comprising nanoparticles, preparation and uses thereof (2019-04-23),

10. 10098952 - Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer (2018-10-16),

11. 10064962 - Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles (2018-09-04),

12. 9956175 - Nanoparticles delivery systems, preparation and uses thereof (2018-05-01),

13. 9700621 - Metallic nanoparticles, preparation and uses thereof (2017-07-11),

14. 9433800 - Activatable particles, preparation and uses (2016-09-06),

15. 9162079 - Activatable particles, preparations and uses (2015-10-20),

Company Overview

Nanobiotix is a biotechnology company based in Paris, France, specializing in the development of innovative cancer therapies. The company focuses on nanomedicine, leveraging its proprietary technology to enhance the efficacy of radiotherapy. By utilizing nanoparticles to improve the delivery and effectiveness of treatment, Nanobiotix aims to provide patients with more effective options for cancer care. Their research and development efforts are centered on advancing therapeutic solutions that address unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#278 in Paris

#1,211 in France

#37,868 in the World

Nanobiotix

Forward Citations = 62

25 inventors:

Laurent Levy (16 out of 27 patents)

Agnes Pottier (9 out of 13 patents)

Matthieu Germain (7 out of 12 patents)

4. Marie-Edith Meyre (6 out of 16 patents)

5. Agnès Pottier (3 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanobiotix. Retrieved from https://idiyas.com/company/nanobiotix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…